Patients who survive STEMI often go on to develop infarct expansion and myocardial thinning which can lead to heart failure and, ultimately, death. In an attempt to limit this phenomenon, several agents have been proposed, amongst them erythropoietin. In addition to its effects on red blood cell production, erythropoietin also stimulates angiogenesis and apoptosis, and […]